EpiminderASX:EPI +1.59%17 EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus rates ASX:EPI with a GF Score™ of 17/100. Among 816 Medical Devices & Instruments companies, Epiminder ranks worse than 122548.9% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Epiminder's EBITDA for the
six
months ended in Dec. 2025 was A$-20.93 Mil. Epiminder's Revenue for the
six
months ended in Dec. 2025 was A$0.00 Mil. Therefore, Epiminder's EBITDA margin for the quarter that ended in Dec. 2025 was 0.00%.
Epiminder (ASX:EPI) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Epiminder EBITDA Margin % Related Terms
Epiminder EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Epiminder's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Epiminder EBITDA Margin % Chart
Epiminder Annual Data
Trend
Jun23
Jun24
Jun25
EBITDA Margin %
0.00
0.00
0.00
Epiminder Semi-Annual Data
Jun23
Jun24
Jun25
Dec25
EBITDA Margin %
0.00
0.00
0.00
0.00
ASX:EPI vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Epiminder's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Epiminder EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Epiminder's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Epiminder's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Epiminder (ASX:EPI) has a EBITDA Margin % of 0.00% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Epiminder and its competitors. According to the industry distribution chart, Epiminder ranks #999999 out of 816 companies in the Medical Devices & Instruments industry.
Is Epiminder's EBITDA Margin % too high?
Epiminder's current EBITDA Margin % is 0.00%. Based on the distribution chart, Epiminder ranks #999999 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Epiminder has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Epiminder's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Epiminder ranks #999999 out of 816 companies for EBITDA Margin %. This places Epiminder in the lower half of its industry. The industry median EBITDA Margin % is 7.39. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.39, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Epiminder and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Epiminder's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Epiminder stock overvalued right now?
Epiminder (ASX:EPI) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Epiminder's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Epiminder (ASX:EPI), the current EBITDA Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Epiminder Ltd is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Its system is a sub-scalp device for continuous monitoring of electrographic brain activity and a set of information solutions, providing patients and their healthcare professionals with detailed data over an extended period.
17GF Score
Get the complete analysis for ASX:EPI
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EPI has been successfully added to your 